Ammonia Solution, Strong

Ammonia Solution, Strong

SCHEMBL6905116

CC(C)(C)C(OC(=O)NC(=O)O)(c1ccc(/C(N)=N\OCc2ccc(F)cc2)cc1)C(C)(C)C.CC(C)(C)C(OC(=O)NC(=O)O)(c1ccc(/C(N)=N\OCc2ccc(F)cc2)cc1)C(C)(C)C.CC(C)(C)C(OC(=O)NC(=O)O)(c1ccc(/C(N)=N\OCc2ccc(F)cc2)cc1)C(C)(C)C.N

nearest known ligand 0.39

Full drug profile on Sugi Atlas →

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
SMN1; SMN2 Q16637 4/20 0.39
S1PR1 P21453 3/20 0.39
KMT2A Q03164 4/20 0.38
MEN1 O00255 2/20 0.38
L3MBTL1 Q9Y468 1/20 0.38
NPC1 O15118 4/20 0.37
RAB9A P51151 3/20 0.37
PKM P14618 2/20 0.37
POLB P06746 1/20 0.36
TNF P01375 1/20 0.35
KLF5 Q13887 1/20 0.35
NOD1 Q9Y239 1/20 0.35
MAOB P27338 1/20 0.35
PARP10 Q53GL7 1/20 0.35
RORC P51449 2/20 0.35
HTT P42858 1/20 0.34
LMNA P02545 1/20 0.33
RXFP1 Q9HBX9 1/20 0.33
NR4A2 P43354 1/20 0.33
PPARG P37231 1/20 0.33

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL6905120 0.89 SMN1; SMN2 (0.38) SMN1; SMN2S1PR1KMT2AMEN1L3MBTL1
SCHEMBL6650316 0.79 SMN1; SMN2 (0.44) SMN1; SMN2S1PR1KMT2AMEN1L3MBTL1
Isobutane SCHEMBL7062276 0.71 NPC1 (0.46) SMN1; SMN2S1PR1KMT2AMEN1L3MBTL1
SCHEMBL7062273 0.69 SMN1; SMN2 (0.39) SMN1; SMN2S1PR1NPC1RAB9APKM
SCHEMBL7062282 0.69 SMN1; SMN2 (0.39) SMN1; SMN2S1PR1NPC1RAB9APKM
SCHEMBL6684012 0.69 NPC1 (0.37) SMN1; SMN2S1PR1KMT2ANPC1RAB9A
Hydrochloric Acid SCHEMBL6794609 0.68 MAOB (0.51) SMN1; SMN2S1PR1NPC1RAB9APKM
Hydrochloric Acid SCHEMBL6672174 0.68 MAOB (0.51) SMN1; SMN2S1PR1NPC1RAB9APKM
SCHEMBL23715924 0.63 L3MBTL1 (0.55) SMN1; SMN2L3MBTL1NPC1RAB9APKM
SCHEMBL14902855 0.63 L3MBTL1 (0.62) SMN1; SMN2L3MBTL1NPC1RAB9APKM

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-20040082585-A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade PHARMACIA CORPORATION 2004-04-29 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20040082585-A1 Prodrugs of substituted polycyclic compounds useful for selective inhibition of the coagulation cascade TFPI, F2, PLG SMN1; SMN2 4186/4885S1PR1 1554/4885KMT2A 3920/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.